Wikidata

(Q64140078)

English

Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients.

clinical trial

In more languages

Statements

short name
REALISE (English)
0 references
title
A Multicenter Phase II, Open Label, Single Arm Study to Evaluate the Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients. (English)
0 references
sponsor
Novartis
0 references
country
Austria
0 references
Belgium
0 references
Bulgaria
0 references
Canada
0 references
Germany
0 references
Greece
0 references
Italy
0 references
Japan
0 references
Spain
0 references
Turkey
0 references
start time
31 March 2017
0 references
end time
24 July 2018
0 references
number of participants
51
0 references
research site
Novartis
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64140078&oldid=1857563214"